DNA testing to determine best choice of antidepressant not yet ready for clinical use. Data to be released in 2019 regarding test’s efficacy and patient outcomes.

Dr. Barry Dworkin

Health Headlines Commentary for June , 2018

[display_podcast]

Source:

New DNA test could end ‘trial and error’ of antidepressant treatments

Reference:

Study is not published as research in ongoing. Data to be released in 2019.

Analysis:

A review of the test by Health Quality Ontario in April of last year found that patients who had the test experienced improved moods and responded better to treatment, but said the scientific evidence was not strong enough to recommend the province fund the test.

Related posts:

  1. Ottawa’s first safe-injection site approved by Health Canada
  2. Most antidepressants do not work for children and adolescents
  3. Study bias against methadone distribution clinics blinds them to the deficiencies of mental health cares services in Ontario
  4. Opiate crisis in Ontario leads to medication updates and increases in support services